Q1 2015 13F Holders as of 3/31/2015
-
Type / Class
-
Equity / American depositary shares, each representing one equity share
-
Shares outstanding
-
835M
-
Number of holders
-
168
-
Total 13F shares, excl. options
-
24.5M
-
Shares change
-
-1.03M
-
Total reported value, excl. options
-
$1.39B
-
Value change
-
-$54.8M
-
Number of buys
-
84
-
Number of sells
-
-70
-
Price
-
$57.10
Significant Holders of DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) as of Q1 2015
183 filings reported holding RDY - DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share as of Q1 2015.
DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) has 168 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24.5M shares
of 835M outstanding shares and own 2.93% of the company stock.
Largest 10 shareholders include Fisher Asset Management, LLC (5.22M shares), COMMONWEALTH BANK OF AUSTRALIA (2.44M shares), AQR CAPITAL MANAGEMENT LLC (1.72M shares), VANGUARD GROUP INC (1.4M shares), BlackRock Group LTD (1.3M shares), Sectoral Asset Management Inc (929K shares), SCHRODER INVESTMENT MANAGEMENT GROUP (692K shares), CAUSEWAY CAPITAL MANAGEMENT LLC (535K shares), DIMENSIONAL FUND ADVISORS LP (525K shares), and ACADIAN ASSET MANAGEMENT LLC (456K shares).
This table shows the top 168 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.